These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 10073959)
1. Intravenous magnesium reduces infarct size after ischemia/reperfusion injury combined with a thrombogenic lesion in the left anterior descending artery. Ravn HB; Moeldrup U; Brookes CI; Ilkjaer LB; White P; Chew M; Jensen L; Johnsen S; Birk-Soerensen L; Hjortdal VE Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):569-74. PubMed ID: 10073959 [TBL] [Abstract][Full Text] [Related]
2. Retrograde infusion of lidocaine or L-arginine before reperfusion reduces myocardial infarct size. Lee R; Nitta T; Schmid RA; Schuessler RB; Harris KM; Gay WA Ann Thorac Surg; 1998 May; 65(5):1353-9. PubMed ID: 9594866 [TBL] [Abstract][Full Text] [Related]
3. [Effect of magnesium on infarct size after coronary occlusion. Animal experiment studies]. Thämer V; Grunert S; Bier F; Schlack W Herz; 1997 Jun; 22 Suppl 1():35-9. PubMed ID: 9333590 [TBL] [Abstract][Full Text] [Related]
4. Lack of effect of glycoprotein IIb/IIIa blockade on myocardial platelet or polymorphonuclear leukocyte accumulation and on infarct size after transient coronary occlusion in pigs. Barrabés JA; Garcia-Dorado D; Mirabet M; Lidón RM; Soriano B; Ruiz-Meana M; Pizcueta P; Blanco J; Puigfel Y; Soler-Soler J J Am Coll Cardiol; 2002 Jan; 39(1):157-65. PubMed ID: 11755302 [TBL] [Abstract][Full Text] [Related]
5. A new model for evaluation of thrombosis and ischaemia/reperfusion injury. Ravn HB; Møldrup U; Ilkjaer LB; Chew M; Jensen L; Johnsen S; Birk-Sørensen L; Tønnesen E; Hjortdal VE APMIS; 2000 May; 108(5):373-9. PubMed ID: 10937776 [TBL] [Abstract][Full Text] [Related]
6. Oxygen radical scavenging agents as adjuvant therapy with tissue plasminogen activator in a canine model of coronary thrombolysis. Przyklenk K; Kloner RA Cardiovasc Res; 1993 Jun; 27(6):925-34. PubMed ID: 8221780 [TBL] [Abstract][Full Text] [Related]
7. Intravenous magnesium sulphate and reperfused myocardium: preservation of function and reduction of infarct size. Feliciano L; Mass HJ Magnes Res; 1996 Jun; 9(2):109-18. PubMed ID: 8878006 [TBL] [Abstract][Full Text] [Related]
8. Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs. Mizumura T; Nithipatikom K; Gross GJ Circulation; 1995 Sep; 92(5):1236-45. PubMed ID: 7648671 [TBL] [Abstract][Full Text] [Related]
9. Time-dependent cardioprotection with calcium antagonism and experimental studies with clevidipine in ischemic-reperfused pig hearts: part II. Segawa D; Sjöquist PO; Wang QD; Gonon A; Rydén L J Cardiovasc Pharmacol; 2002 Sep; 40(3):339-45. PubMed ID: 12198319 [TBL] [Abstract][Full Text] [Related]
10. Selective Inhibition of Succinate Dehydrogenase in Reperfused Myocardium with Intracoronary Malonate Reduces Infarct Size. Valls-Lacalle L; Barba I; Miró-Casas E; Ruiz-Meana M; Rodríguez-Sinovas A; García-Dorado D Sci Rep; 2018 Feb; 8(1):2442. PubMed ID: 29402957 [TBL] [Abstract][Full Text] [Related]
11. Bradycardic agent UL-FS 49 attenuates ischemic regional myocardial dysfunction and reduces infarct size in swine: comparison with the beta-blocker atenolol. Schulz R; Rose J; Skyschally A; Heusch G J Cardiovasc Pharmacol; 1995 Feb; 25(2):216-28. PubMed ID: 7752647 [TBL] [Abstract][Full Text] [Related]
12. Local beta-adrenergic blockade does not reduce infarct size after coronary occlusion and reperfusion: a study of coronary venous retroinfusion of metoprolol. Kobayashi S; Tadokoro H; Rydén L; Sjöquist PO; Haendchen RV; Corday E Cardiovasc Drugs Ther; 1993 Feb; 7(1):159-67. PubMed ID: 8097926 [TBL] [Abstract][Full Text] [Related]
13. Magnesium sulfate reduces myocardial infarct size when administered before but not after coronary reperfusion in a canine model. Christensen CW; Rieder MA; Silverstein EL; Gencheff NE Circulation; 1995 Nov; 92(9):2617-21. PubMed ID: 7586364 [TBL] [Abstract][Full Text] [Related]
14. Reduction in reperfusion-induced myocardial necrosis in dogs by RheothRx injection (poloxamer 188 N.F.), a hemorheological agent that alters neutrophil function. Schaer GL; Hursey TL; Abrahams SL; Buddemeier K; Ennis B; Rodriguez ER; Hubbell JP; Moy J; Parrillo JE Circulation; 1994 Dec; 90(6):2964-75. PubMed ID: 7994844 [TBL] [Abstract][Full Text] [Related]
15. Infarct salvage with liposomal prostaglandin E1 administered by intravenous bolus immediately before reperfusion in a canine infarction-reperfusion model. Smalling RW; Feld S; Ramanna N; Amirian J; Felli P; Vaughn WK; Swenson C; Janoff A Circulation; 1995 Aug; 92(4):935-43. PubMed ID: 7641377 [TBL] [Abstract][Full Text] [Related]